Page last updated: 2024-10-27

flumazenil and Dysplasia Linguofacialis

flumazenil has been researched along with Dysplasia Linguofacialis in 1 studies

Flumazenil: A potent benzodiazepine receptor antagonist. Since it reverses the sedative and other actions of benzodiazepines, it has been suggested as an antidote to benzodiazepine overdoses.
flumazenil : An organic heterotricyclic compound that is 5,6-dihydro-4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted at positions 3, 5, 6, and 8 by ethoxycarbonyl, methyl, oxo, and fluoro groups, respectively. It is used as an antidote to benzodiazepine overdose.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Cocciadiferro, D1
Agolini, E1
Digilio, MC1
Sinibaldi, L1
Castori, M1
Silvestri, E1
Dotta, A1
Dallapiccola, B1
Novelli, A1

Other Studies

1 other study available for flumazenil and Dysplasia Linguofacialis

ArticleYear
The splice c.1815G>A variant in KIAA0586 results in a phenotype bridging short-rib-polydactyly and oral-facial-digital syndrome: A case report and literature review.
    Medicine, 2020, Volume: 99, Issue:8

    Topics: Cell Cycle Proteins; Ciliopathies; Humans; Infant, Newborn; Italy; Male; Orofaciodigital Syndromes;

2020